We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
TD Cowen analyst Phil Nadeau maintained a Buy rating on Atara Biotherapeutics (ATRA – Research Report) yesterday. The company’s shares closed last Friday at $6.90. See what stocks are ...
Atara Biotherapeutics (ATRA) came out with a quarterly loss of $1.19 per share versus the Zacks Consensus Estimate of a loss of $3.82. This compares to loss of $14 per share a year ago.
ATRA opened at $6.91 on Wednesday. Atara Biotherapeutics has a 12 month low of $5.40 and a 12 month high of $23.44. The stock has a market cap of $39.80 million, a P/E ratio of -0.27 and a beta of ...
Artist Naja Elon Webb (left) in front of her work at her recent graduation from Duke Ellington School of the Arts, is tackling female oppression through her series, “A Scary Time to be a Man ...
Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA. Jul 27, 2022 10:49am ET ATRA INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results